Successful Companion Diagnostics Programs: Experiences of a Global Central Laboratory

Get in Touch

Our Locations

Alan Wookey

Successful Companion Diagnostics Programs: Experiences of a Global Central Laboratory

World CDx Boston 2019

This presentation reviews the central laboratory’s role and best practices for executing companion diagnostics globally. It focuses on key attributes required for complex oncology trials, and highlights CDx development in China. Q²Solutions presented this during the World CB and CDx Boston 2019 conference.

Download this presentation to learn more.

Related Services & Solutions

Related Thought Leaders Insights

Factsheet

Your clinical trial sample tracking solution — enhanced

Subject samples are the lifeblood of your clinical trials. To be successful, you need a unique solution that can track samples through their full lifecycles — across the ecosystem of sites, labs,...

Scientific Poster

Evaluation of Single Cell RNA Sequencing from FFPE Tissue using 10x Genomics Chromium Gene Expression Flex Assay

Single cell RNA sequencing (scRNA-seq) uncovers tissue heterogeneity by providing gene expression measurements in individual cells within a tissue. A current limitation of scRNA-seq is the...

Scientific Poster

Comprehensive Genomic Profiling in FFPE Tissue Sample using TruSight Oncology 500 Assay

Next generation sequencing (NGS)-based comprehensive genomic profiling has emerged as a powerful tool for the large-scale detection of genomic changes. TruSight Oncology 500 (TSO500) Assay employs a...